Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Svetlana Bezhanova"'
Publikováno v:
International Journal of Biomedicine, Vol 9, Iss Suppl_1, Pp S33-S33 (2019)
Background: The differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is clinically significant because of their different biological behavior: the former widely accepted as a benign neoplasm and the latter
Externí odkaz:
https://doaj.org/article/b9c2059977c1479aa2c037ecdee788b5
Publikováno v:
SDRP Journal of Anesthesia & Surgery. 3:160-167
Patients with colorectal cancer (CRC) are more likely to become infected with COVID-19 than healthy individuals. The risk of comlications and death in COVID-19 positive colorectal cancer patients is higher due to treatments that suppress the immune s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bb95392a400c98ef322069dad69efbf
https://doi.org/10.25177/jas.3.2.ra.10718
https://doi.org/10.25177/jas.3.2.ra.10718
Autor:
Svetlana Bezhanova, Assoc. Prof. Stoyanka Dineva, Petar Spasov, Assoc. Prof. Branimir Golemanov
Point-of-care ultrasound (POCUS) is a non-invasive diagnostic bedside imaging modality which is a fast, safe, accurate and valuable tool for diagnosing gastrointestinal pathology, clinical decision making in emergency situations within a very short t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a20dc0c2f0157f9e73d3370a5858ad4
Publikováno v:
International Journal of Biomedicine, Vol 9, Iss Suppl_1, Pp S33-S33 (2019)
Background: The differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is clinically significant because of their different biological behavior: the former widely accepted as a benign neoplasm and the latter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d8848e7bba771d164f9daa37870bbf
https://doi.org/10.21103/ijbm.9.suppl_1.p37
https://doi.org/10.21103/ijbm.9.suppl_1.p37
Autor:
Jens M. Seeger, Peter Möller, H. Christian Reinhardt, Alexander N.R. Weber, Louis M. Staudt, Maurice Reimann, Stephan C. Schäfer, Paul Liedgens, Matthias Schlesner, Manolis Pasparakis, Darya Korovkina, Clemens A. Schmitt, Margarete Odenthal, Gero Knittel, F. Thomas Wunderlich, Lorenz Trümper, Hamid Kashkar, Reinhard Büttner, Mona Al-Maarri, Katerina Vlantis, Manuel Montesinos-Rongen, Philipp Lohneis, Svetlana Bezhanova, Reiner Siebert, Andreas H. Scheel, Lukas P. Frenzel, Cristina López, Andreas R. Klatt, Thorsten Persigehl, Monika Ortmann, Christian Fritz, Yussor Al-Baldawi, Olaf-Oliver Wolz
Publikováno v:
Blood. 127(22)
The adaptor protein MYD88 is critical for relaying activation of Toll-like receptor signaling to NF-κB activation. MYD88 mutations, particularly the p.L265P mutation, have been described in numerous distinct B-cell malignancies, including diffuse la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b15a665e2e28fcb71f9f1297f229115
https://pubmed.ncbi.nlm.nih.gov/27257177
https://pubmed.ncbi.nlm.nih.gov/27257177